Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
16.31
0.00 (0.00%)
At close: Mar 27, 2026, 4:00 PM EDT
16.35
+0.04 (0.25%)
After-hours: Mar 27, 2026, 5:31 PM EDT
Pharming Group Market Cap
Pharming Group has a market cap or net worth of $1.12 billion as of March 27, 2026. Its market cap has increased by 87.91% in one year.
Market Cap
1.12B
Enterprise Value
1.05B
1-Year Change
87.91%
Ranking
Category
Stock Price
$16.31
Market Cap Chart
Since June 16, 1999, Pharming Group's market cap has increased from $128.85M to $1.12B, an increase of 767.24%. That is a compound annual growth rate of 8.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 1.12B | -2.08% |
| Dec 31, 2025 | 1.15B | 76.58% |
| Dec 31, 2024 | 649.63M | -14.84% |
| Dec 29, 2023 | 762.86M | 0.93% |
| Dec 30, 2022 | 755.82M | 32.18% |
| Dec 31, 2021 | 571.80M | -42.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ORIC Pharmaceuticals | 1.21B |
| Olema Pharmaceuticals | 1.20B |
| Vir Biotechnology | 1.20B |
| DBV Technologies | 1.19B |
| Corvus Pharmaceuticals | 1.19B |
| Taysha Gene Therapies | 1.17B |
| Septerna | 1.08B |
| Savara | 1.06B |